Ricalde, Alvin M.
HRN: 22-20-92 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/17/2025
CEFTRIAXONE 1G (VIAL)
10/17/2025
10/23/2025
IV
2g
Od
Complicated Uti
Waiting Final Action
Indication: Empirical De-escalation Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes